Search
Cadrenal Therapeutics Inc
CVKDAdd to Watchlist
2.035USD
-0.055-2.63%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.10MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
2
analysts
Buy
Current Rating
16.667
Target Price
+746.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Cadrenal Therapeutics Inc
CVKD
2
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Cadrenal Therapeutics IncCVKD's recent earnings per share performed?
The market expectation was USD -1.04, while Cadrenal Therapeutics IncCVKD's earnings per share (EPS) for the previous quarter was USD -1.43. EPS for the next quarter is expected at USD -1.42.
What is the analyst rating for Cadrenal Therapeutics Inc?
Based on the ratings of Cadrenal Therapeutics Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.